KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to -$2.5 billion.

  • Eli Lilly's Net Cash Flow fell 85027.49% to -$2.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.6 billion, marking a year-over-year increase of 38632.71%. This contributed to the annual value of $3.6 billion for FY2025, which is 38632.71% up from last year.
  • According to the latest figures from Q4 2025, Eli Lilly's Net Cash Flow is -$2.5 billion, which was down 85027.49% from $6.4 billion recorded in Q3 2025.
  • In the past 5 years, Eli Lilly's Net Cash Flow registered a high of $6.4 billion during Q3 2025, and its lowest value of -$2.5 billion during Q4 2025.
  • For the 5-year period, Eli Lilly's Net Cash Flow averaged around $187.0 million, with its median value being $2.6 million (2022).
  • As far as peak fluctuations go, Eli Lilly's Net Cash Flow plummeted by 1668947.37% in 2023, and later skyrocketed by 793349.69% in 2025.
  • Quarter analysis of 5 years shows Eli Lilly's Net Cash Flow stood at $251.0 million in 2021, then plummeted by 268.21% to -$422.2 million in 2022, then skyrocketed by 173.07% to $308.5 million in 2023, then increased by 6.13% to $327.4 million in 2024, then plummeted by 850.27% to -$2.5 billion in 2025.
  • Its last three reported values are -$2.5 billion in Q4 2025, $6.4 billion for Q3 2025, and $7.1 million during Q2 2025.